|
..............Current Issue - May 2009.............
|
|
Cover Story
Slow but Steady Indian Pharma Machinery Manufacture Comes
of Age
It is significant to note that India and China are making machinery that are 10-20 times less expensive as compared to those made in the US and Europe. Moreover, Indian Pharma machines are also gaining global acceptance...
|
|
FEATURES
India - The Diabetes R&D Destination of Choice
Diabetes is a highly prevalent and debilitating disease condition worldwide and is associated with major cardiovascular, renal and blindness related complications leading to several diabetes-induced deaths. According to the World Health Organization (WHO), India is the Diabetes Capital of the world with over 40.9 million Indians suffering from diabetes. More worrying is the alarming rate at which this disease is spreading - diabetes incidence has increased steadily in the last half of this century due to diet, lifestyle and stress-related factors and in the last 30 years alone, the number of urban Indian diabetics has increased by 10 times. This has also led to a rapid increase in diabetes related clinical trials in India. Out of roughly a 1000 trials currently happening in India, approximately 150 i.e. 15% are in Diabetes. This article highlights the seriousness of the disease and opportunity for diabetes research and trials in India with emphasis on the specific challenges faced and emerging responses to the challenges...
End-to-End Integration of HD Devices In The Operating Room Ushers In A New Era In Disruptive Technology
NIR chemical imaging greatly extends the capability of NIR spectroscopy, and is the only PAT-applicable blend monitoring technique that gives both statistical and direct information about individual sample components on the micro scale...
|
|
|
CORPORATE AFFAIRS
Alliances & Acquisition
Global Pain Management Plans to Expand its Transdermal Patches and Gels Business to USD 8 Billion in 2012
Nashua, NH : The growing incidence of diseases and conditions related to aging is creating pockets of opportunity for pain management. These opportunities include the expanding use of prescription NSAIDs as second-line therapies for chronic pain and an increase in off-label prescribing. As populations and indications evolve, so too is the pain management sector. Traditionally dominated by tablets and specialty injectables, today's pipeline is heavily represented by pain drugs designed for alternative delivery methods - often generic drugs that possess attractive economic and safety benefits.Responding to the simplified dosing, reduced side effects and relative safety of transdermal pain patches and gels, more than two dozen drug developers - either independently or in partnership - are investing in the clinical development of a diverse range of pain drugs that can be delivered through the skin...
Teikoku Pharma Acquires Travanti Pharma to Develop Transdermal Pharmaceutical Products
California: Teikoku Pharma USA Inc., the international specialty pharmaceutical company, has announced to have acquired effective Minneapolis area-based Travanti Pharma Inc, a privately held corporation that designs, develops and markets innovative drug delivery platforms that improve the safety, compliance, effectiveness and ease of administration of medications delivered to the body...
Dr. Reddy receives the American India Foundation - 2009 Award
The American India Foundation (AIF) on 11th May, 2009 honored Chairman, Dr. K Anji Reddy with the prestigious AIF - Annual Spring award.
The brainchild of President Clinton, AIF was founded in 2001, and is the leading Indian diaspora Foundation focused on helping underprivileged in India, and is acknowledged as a trusted bridge for Americans to channel their philanthropy toward India...
|
|
Launches
Ranbaxy launches clinical trials for anti-malaria drug
MUMBAI: Pharma firm Ranbaxy Laboratories has launched clinical trials for its anti-malaria drug Arterolanc maleate Piperaquine phospahate in three countries including India.
In a filing to the Bombay Stock Exchange, the company official said "it has commenced the Phase-III clinical trials for its new anti-malaria combination drug in India, Bangladesh and Thailand...
Medtronic's New spinal products to Upgrade Cervical Procedures
Medtronic Inc. has launched two new spinal products in the U.S. market, both of them for cervical procedures.
The Vertex Select Reconstruction System Occipitocervical Module is used when spinal conditions require the base of the skull to be fused to the neck. Vertex is an implant system and an instrument set for the procedure...
|
|
|
|
|
